This integrative review of 16 studies suggests ketogenic therapies targeting brain metabolic pathways may improve PTSD, though robust human clinical trials remain lacking.
New Results: First RCT for Schizophrenia & Bipolar Disorder. Learn more.
This integrative review of 16 studies suggests ketogenic therapies targeting brain metabolic pathways may improve PTSD, though robust human clinical trials remain lacking.
This perspective review examines bipolar disorder through a metabolic lens. It highlights how nutrition, seasonal light, and metabolic shifts may contribute to symptom instability.
Read more
Lamotrigine treats both epilepsy and bipolar disorder via shared neurobiology. This review explores whether therapeutic ketosis may synergistically enhance mood stabilization and metabolic health.
Read more
This review suggests low-carbohydrate and ketogenic diets show clinical potential for reducing depressive and anxiety symptoms as adjunctive therapies for treatment-resistant mental health conditions.
Read more